RANDAL J KIRK SC 13D 12-8-2014 (HISTOGENICS CORPORATION)

Company

Ocugen, Inc.

Filed

December 10, 2014

Accession Number

0001140361-14-044760

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →